Medicine
Opinion: Low-income parents can’t afford to take chances with nutritious food their picky eaters might reject
“Children's food refusals come at a cost — one that few cash-strapped families can afford,” experts write.
A new tactic in the war over out-of-network bills: Health care providers are suing employers
Providers increasingly are suing employers, claiming they are responsible for out-of-network medical bills that insurers haven’t fully paid or have delayed paying.
STAT+: Doctors on Kennedy’s influential preventive care panel have major conflicts of interest, filings reveal
Federal health officials granted blanket ethics waivers to USPSTF panel members, some of whom own pharma stocks and private medical practices.
STAT+: MDCalc launches a ‘rumble strip’ for doctors using generative AI tools
MDCalc, a medical reference tool site, is launching CrossCover, a tool meant to help clinicians trust the answers of medical AI chatbots.
Disabled people in England ‘have to wait up to two years for wheelchairs’
Ombudsman’s report says delays have profound consequences and limit users’ ability to lead independent livesDisabled people are having to wait up to two years to get a wheelchair …
STAT+: Democrats take new step toward investigating Trump’s drug pricing deals
Incoming Democratic chairs of key committees have taken a step toward investigating MFN drug pricing agreements between drugmakers and the Trump administration.
STAT+: Wyden, Sanders hand-in-hand on ‘Medicare for All’ initiative
Sen. Bernie Sanders said that he wants to lower the Medicare eligibility age by 10 years, among other initiatives.
STAT+: Former Eli Lilly rep claims she was fired for complaining about marketing of Mounjaro diabetes drug
A former Eli Lilly sales rep filed a lawsuit alleging she was fired after claiming the company was inappropriately promoting its Mounjaro diabetes drug to combat weight loss.
STAT+: Men’s use of chatbots for therapy, and earnings season highlights
In this edition of STAT Health Tech: Growing optimism around chatbots and men who avoid therapy, and highlights from the earnings season.
STAT+: Oura to acquire Counsel Health for $625 million, placing a big bet on AI care
Oura, the smart ring maker that recently delayed plans to go public, said it will pay $625 million to acquire Counsel Health, a clinical AI startup.
People in deprived areas of England more than ‘twice as likely’ to die prematurely
Early death risk for men and women in most deprived areas 2.3 times higher than those more affluent, study showsPeople living in the most deprived areas of England are more than t…
The vaccine limbo in the US is worsening the measles outbreak
Earlier doses for children, a focus on unvaccinated adults, a risk strategy based on geography – here’s how a functioning ACIP would address the measles outbreakThe US has announc…
STAT+: GLP-1s are given an FDA warning for rare eye condition risk
The FDA warned that GLP-1 drugs carry a potential risk of a rare but serious eye condition sometimes referred to as an “eye stroke.”
STAT+: Pharmalittle: We’re reading about an approval for novel drug for strokes, a warning for GLP-1 drugs, and more
The FDA approved a novel drug to reduce recurrence of stroke, the agency is warning that GLP-1s carry a potential risk for an eye condition, and more pharma news of…
Selena Gomez says vaping has changed her voice. Can e-cigarettes really affect your vocal cords – and is it reversible?
Experts say the practice can damage delicate tissues in the voice box and there is not yet sufficient data to say if people can recoverRead more in the Antiviral seriesWhile vapin…
STAT+: Dutch antitrust regulators probe Biogen over test for its MS drug
Dutch anti-trust regulators are investigating allegations that Biogen may have abused its dominant position in the market for MS treatments and associated blood tests.
STAT+: Pharma is a ‘mixed bag’ when providing drug access to low- and middle-income countries, analysis finds
Many large pharmaceutical companies are taking steps to improve access to their medicines in low- and middle-income countries, but progress has been mixed.
Why this year’s flu season could be hitting teens and young adults hard
At least 1.7 million cases of flu have been reported so far this year. Here's what experts are expecting for the rest of flu season:
STAT+: PepGen says early trial for muscular dystrophy drug looks promising
PepGen says its candidate is correcting more of the genetic stutter found in myotonic dystrophy type 1.
Opinion: STAT+: BIO CEO: American biotech needs a coordinated plan to beat China — now
BIO CEO: “Today’s biotech race is our generation’s Space Race.”
Opinion: AI’s health advice can be accurate and still make us sicker
“Even a factually accurate health message can change behavior in ways that make people less healthy,” researchers write.
STAT+: State Democratic wins make Medicaid expansion a possibility for more than a million people
Texas, Georgia, and Wisconsin may expand their Medicaid programs when Democrats take power.
STAT+: Ionis Pharmaceuticals shares plummet after slow rollout of biotech’s triglyceride-lowering drug
Ionis Pharmaceuticals lost more than $1 billion in market value on Monday after the company slashed sales projections for a triglyceride-lowering drug.
STAT+: FDA approves novel Bayer drug to reduce recurrence of stroke
Bayer's drug is the first in a novel class of medications designed to prevent blood clots without increasing risk of bleeding.